Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF–mediated myelopoiesis
Peer W. F. Karmaus(St. Jude Children's Research Hospital), Hongbo Chi(St. Jude Children's Research Hospital), Julián Ávila-Pacheco(Broad Institute), Peter Vogel(Lexicon Pharmaceuticals (United States)), Clary B. Clish(Broad Institute), Andrés A. Herrada(University of Concepción), Yogesh Dhungana(St. Jude Children's Research Hospital), Cliff Guy(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital)
Cited by 52
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996